Current status of antiangiogenic therapies for glioblastomas.
about
miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks3D microtumors in vitro supported by perfused vascular networks.Phase I trial of aflibercept (VEGF trap) with radiation therapy and concomitant and adjuvant temozolomide in patients with high-grade gliomas.Lentivirus-mediated Nox4 shRNA invasion and angiogenesis and enhances radiosensitivity in human glioblastoma.Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.Hyperthermotherapy enhances antitumor effect of 5-aminolevulinic acid-mediated sonodynamic therapy with activation of caspase-dependent apoptotic pathway in human glioma.Talin1 targeting potentiates anti-angiogenic therapy by attenuating invasion and stem-like features of glioblastoma multiforme.Targeted Proteomics to Assess the Response to Anti-Angiogenic Treatment in Human Glioblastoma (GBM).Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.Resistance to antiangiogenic therapy.Bevacizumab and glioblastoma: scientific review, newly reported updates, and ongoing controversies.Glioblastoma stem cells exploit the αvβ8 integrin-TGFβ1 signaling axis to drive tumor initiation and progression.Stable knockdown of LRG1 by RNA interference inhibits growth and promotes apoptosis of glioblastoma cells in vitro and in vivo.AG488 as a therapy against gliomas.Diagnostic Value of Fractal Analysis for the Differentiation of Brain Tumors Using 3-Tesla Magnetic Resonance Susceptibility-Weighted Imaging.
P2860
Q26781836-64796A5E-88DF-4283-83E8-65A74719FD84Q27317186-8F5B6F9A-614C-49D3-AA48-886FA3D9D3F0Q33438666-1C7699A3-9706-4CB3-B505-A8893FC598FAQ33607328-C0CCECB3-2B6D-49D3-9A15-AF6A59872DE4Q34943946-9DE53F30-CB9E-4BC7-9102-580C9F3C3A37Q35914670-5DCBF89E-49FD-47B2-956F-B594D463E519Q36413742-39440ED0-ECCC-487D-867F-851281C98B63Q36539474-925CB29B-0748-4F96-82DD-699759E50DF8Q37407395-84BC333F-D24A-43BF-BBA0-5B418538A8FAQ37536654-46801653-184A-4D59-8812-DF831C9E6365Q38197943-3520BAC3-102F-494D-B332-2D92F47C028FQ38255001-9056CFE5-FE62-4D52-A8F1-F5D08E1D89DAQ38637150-C214EFC8-7B8B-4C44-899E-DED06CC0AC9BQ38919894-45519DDE-ED53-4FF3-A0A5-CC1E73849EA0Q42700872-41B812E4-7E31-41FE-8552-7C5609D5A823Q48662054-D50A6D2D-EA1B-453A-9A86-C063CBC6025A
P2860
Current status of antiangiogenic therapies for glioblastomas.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current status of antiangiogenic therapies for glioblastomas.
@en
type
label
Current status of antiangiogenic therapies for glioblastomas.
@en
prefLabel
Current status of antiangiogenic therapies for glioblastomas.
@en
P2860
P1476
Current status of antiangiogenic therapies for glioblastomas.
@en
P2093
Isabel Arrillaga-Romany
Patrick Y Wen
P2860
P304
P356
10.1517/13543784.2014.856880
P407
P577
2013-12-10T00:00:00Z